256 related articles for article (PubMed ID: 2785135)
21. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
Geppert TD; Lipsky PE
J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
[TBL] [Abstract][Full Text] [Related]
22. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
23. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
24. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
Pawelec G; Schneider EM; Müller C; Wernet P
Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
[TBL] [Abstract][Full Text] [Related]
25. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
[TBL] [Abstract][Full Text] [Related]
26. Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.
Dohlsten M; Lando PA; Hedlund G; Trowsdale J; Kalland T
Immunology; 1990 Sep; 71(1):96-100. PubMed ID: 2210803
[TBL] [Abstract][Full Text] [Related]
27. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
28. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
Merkenschlager M; Altmann DM; Ikeda H
J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
[TBL] [Abstract][Full Text] [Related]
29. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.
Nickoloff BJ; Mitra RS; Green J; Zheng XG; Shimizu Y; Thompson C; Turka LA
J Immunol; 1993 Mar; 150(6):2148-59. PubMed ID: 8450207
[TBL] [Abstract][Full Text] [Related]
30. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
Fischer A; Sterkers G; Charron D; Durandy A
Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
[TBL] [Abstract][Full Text] [Related]
31. Influence of HLA class I- and class II-specific monoclonal antibodies on DR-restricted lymphoproliferative responses. I. Unseparated populations of effector cells.
Sterkers G; Henin Y; Kalil J; Bagot M; Levy JP
J Immunol; 1983 Dec; 131(6):2735-40. PubMed ID: 6227663
[TBL] [Abstract][Full Text] [Related]
32. Differential abilities of human peripheral blood monocytes quantitatively or qualitatively differing in HLA-DR and HLA-DS expression to support B cell activation in liquid and semisolid cultures.
Whisler RL; Newhouse YG; Lachman LB
J Immunol; 1985 Jul; 135(1):172-9. PubMed ID: 3873488
[TBL] [Abstract][Full Text] [Related]
33. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
34. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
35. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
36. Enhancing effect of anti-HLA class I monoclonal antibodies on T cell proliferation induced via CD2 molecule.
Turco MC; de Felice M; Corbo L; Giarrusso PC; Yang SY; Ferrone S; Venuta S
J Immunol; 1988 Oct; 141(7):2275-81. PubMed ID: 3262654
[TBL] [Abstract][Full Text] [Related]
37. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
38. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
[TBL] [Abstract][Full Text] [Related]
39. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a human T cell line reactive to a 52 kDa islet protein.
Sobel DO; Fleisher T; Karounos DG
J Autoimmun; 1997 Aug; 10(4):387-94. PubMed ID: 9237802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
